Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3065 |
|
Actual shortage: | 231 (8%) | |
Anticipated shortage: | 16 (1%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2809 (92%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
30 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-AMLODIPINE-ATORVASTATIN | 5MG 80MG | TABLET | Resolved | 2018-01-31 | 2018-07-03 | 37717 |
APO-CINACALCET | 60MG | TABLET | Resolved | 2018-01-31 | 2018-11-23 | 37726 |
APO-CIPROFLOX | 250MG | TABLET | Resolved | 2018-01-31 | 2018-09-09 | 37729 |
APO-PRAVASTATIN | 40MG | TABLET | Resolved | 2018-01-31 | 2018-05-09 | 37737 |
APO-QUINAPRIL | 5MG | TABLET | Resolved | 2018-01-31 | 2018-05-25 | 37740 |
APO-TERAZOSIN | 1MG | TABLET | Resolved | 2018-01-31 | 2018-07-31 | 37743 |
APO-TERBINAFINE | 250MG | TABLET | Resolved | 2018-01-31 | 2018-09-21 | 37746 |
APO-TETRABENAZINE | 25MG | TABLET | Resolved | 2018-01-31 | 2018-05-16 | 37749 |
APO-AMLODIPINE-ATORVASTATIN | 5MG 10MG | TABLET | Resolved | 2018-02-01 | 2018-07-03 | 37945 |
APO-ENALAPRIL | 10MG | TABLET | Resolved | 2018-02-01 | 2018-04-07 | 37949 |
APO-ENALAPRIL | 5MG | TABLET | Resolved | 2018-02-01 | 2018-04-07 | 37953 |
APO-EZETIMIBE | 10MG | TABLET | Resolved | 2018-02-01 | 2018-04-23 | 37956 |
APO-NAPROXEN | 250MG | TABLET | Resolved | 2018-02-01 | 2018-04-05 | 37971 |
APO-QUETIAPINE | 100MG | TABLET | Resolved | 2018-02-01 | 2018-04-15 | 37974 |
APO-QUETIAPINE | 25MG | TABLET | Resolved | 2018-02-01 | 2018-04-17 | 37977 |
APO-QUETIAPINE | 300MG | TABLET | Resolved | 2018-02-01 | 2018-04-24 | 37980 |
APO-TADALAFIL | 20MG | TABLET | Resolved | 2018-02-01 | 2018-05-15 | 37983 |
APO-TERAZOSIN | 2MG | TABLET | Resolved | 2018-02-01 | 2018-08-20 | 37986 |
APO-TERBINAFINE | 250MG | TABLET | Resolved | 2018-02-01 | 2018-04-15 | 37989 |
APO-OLANZAPINE | 20.0MG | TABLET | Resolved | 2018-02-01 | 2018-05-25 | 37997 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94446 | ||
APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94449 | ||
APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94452 | ||
APO-HYDROCHLOROTHIAZIDE | Discontinued | 2019-11-26 | 2019-11-26 | 99653 | ||
APO-IMIQUIMOD | Discontinued | 2019-11-26 | 2019-11-26 | 99672 | ||
APO-CARBAMAZEPINE | Discontinued | 2020-02-19 | 2020-02-19 | 106679 | ||
APO-NIZATIDINE | 150MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1127 |
APO-NIZATIDINE | 300MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1135 |
APO-NORTRIPTYLINE | 10MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1145 |
APO-NORTRIPTYLINE | 25MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1155 |
APO-GEMFIBROZIL CAP 300MG USP | 300MG | CAPSULE | Discontinued | 2017-03-31 | 2018-12-07 | 4920 |
APO-DOCUSATE SODIUM | 100MG | CAPSULE | Discontinued | 2018-02-23 | 2019-03-29 | 40733 |
DOCUSATE SODIUM CAPSULES | 100MG | CAPSULE | Discontinued | 2018-02-23 | 2018-09-15 | 40738 |
APO-AMOXI | 250MG | CAPSULE | Discontinued | 2018-09-07 | 2019-02-13 | 60171 |
APO-AMOXI | 500MG | CAPSULE | Discontinued | 2018-09-07 | 2018-11-09 | 60174 |
APO-ATOMOXETINE | 60MG | CAPSULE | Discontinued | 2018-09-07 | 2018-09-15 | 60273 |
APO-CELECOXIB | 100MG | CAPSULE | To be discontinued | 2018-09-07 | 2018-12-11 | 60363 |
APO-CELECOXIB | 200MG | CAPSULE | Discontinued | 2018-09-07 | 2021-01-21 | 60366 |
APO-CLINDAMYCIN | 150MG | CAPSULE | To be discontinued | 2018-09-07 | 2018-12-28 | 60396 |
APO-CLINDAMYCIN | 300MG | CAPSULE | Discontinued | 2018-09-07 | 2019-07-13 | 60399 |